@chanelica.r's Ozempic makeup routine skips the health talk

What did @chanelica.r actually say?

Chanel, a PCOS patient who says she has been on GLP-1 medications for 63 weeks, lays out five things she recommends doing before your first injection. Her list: build a tracking spreadsheet, calculate your protein needs, hit daily water goals, stock OTC remedies for side effects, and "pre-game" before your shot, meaning eat protein and get fluids in beforehand. She frames all of this as practical prep from hard-won personal experience, not medical advice. To her credit, she never says these are guarantees and consistently tells viewers to learn what works for their own body.

She also shares personal results: going from 246 to 162 pounds in 63 weeks, dropping her A1C from prediabetic range to 5.3, and getting her PCOS and cholesterol "under control." These are anecdotal, but they are specific and plausible given the published literature on semaglutide outcomes.

Does the science back this up?

Most of it, actually, yes. The advice to track doses, injection sites, and weight is standard clinical practice. The emphasis on protein to preserve lean mass is one of the most evidence-supported concerns in GLP-1 prescribing right now. Water and electrolyte intake are also genuinely relevant, given the nausea and appetite suppression these drugs cause.

A 2023 paper by Wilding and colleagues in Diabetes, Obesity and Metabolism confirmed that semaglutide-related weight loss includes a meaningful proportion of lean mass, with some estimates suggesting 25-40% of total weight lost may be lean tissue. That makes adequate protein intake not a wellness trend but a real clinical concern. The SUSTAIN and SCALE trial data also document nausea, constipation, and diarrhea as the most common adverse events, so stocking those OTC remedies is genuinely practical. Electrolyte loss during periods of reduced intake and vomiting is also documented, though daily electrolyte supplementation is not a formal clinical recommendation and should be discussed with a provider.

What did they get wrong (or right)?

Chanel gets a lot right here. Tracking injections by site is actually clinically useful, since rotating sites reduces lipohypertrophy risk. Her protein framing is solid. Her side-effect prep list is reasonable and does not recommend anything alarming.

Where she gets vague is on protein quantity. She says "everybody's protein is going to be different" without giving any framework, which is true but not particularly useful. Current guidance from obesity medicine specialists generally suggests 1.2 to 1.6 grams of protein per kilogram of body weight for people on GLP-1 agents who are actively losing weight, based on recommendations from the Obesity Medicine Association. Viewers are left to figure that out on their own.

The "pre-gaming" concept, eating protein before injecting to blunt side effects, is widely discussed in patient communities but lacks formal clinical trial evidence. It is plausible mechanistically, since food in the stomach may slow gastric emptying effects, but it is not a studied protocol. She does caveat it appropriately: "it's not a guarantee." That is fair.

One minor issue: she refers to the medication as "olympic" repeatedly, which is a transcription artifact, but worth flagging since medication name accuracy matters when patients are searching for information.

What should you actually know?

This video is one of the better-constructed patient experience posts in the GLP-1 space. The advice is mostly practical and does not cross into dangerous territory. But a few things matter here that a TikTok cannot cover.

• Lean mass loss is a real concern. Ask your prescriber about resistance training, not just protein. A 2022 study by Bray and Ryan in Nature Reviews Endocrinology found that exercise combined with GLP-1 therapy improved body composition outcomes compared to medication alone.
• OTC remedies like antidiarrheal pills and stool softeners are fine for occasional use, but persistent GI symptoms on GLP-1s can sometimes signal a dose that needs adjustment, not just symptom management. That conversation belongs with your provider.
• Daily electrolyte supplementation may be appropriate for some patients but is not universally recommended. Sodium, potassium, and magnesium needs vary significantly by individual. Do not stack supplements without guidance.
• Her A1C improvement from prediabetic range to 5.3 is plausible and consistent with published outcomes, but GLP-1 medications are not a cure for metabolic conditions. Stopping medication without a supervised plan can reverse those gains.